Summer 2017 Cohort
Evgeny Bondarenko is a postdoctoral researcher at UCLA interested in starting a company to create convolutional neural networks for the analysis of histological preparations in neuroscience research. Bondarenko holds a Bachelor of Psychology from the University of Newcastle and a Ph.D. in human physiology from the University of Newcastle. He is joined by team member Marcos Otero-Garcia, a UCLA postdoctoral researcher.
Gayle Boxx is the founder, president and CEO of Aukera, Inc. Aukera has developed manufacturing and packaging technologies for the vault nanoparticle that make it an affordable and effective nanodelivery platform. Boxx holds a B.S. in biology from CSU Chico, a M.S. in microbiology from Cal State Long Beach, and a Ph.D. in microbiology, immunology and molecular genetics from UCLA. She is joined by team member Jan Mrazek, co-founder and chief scientific officer of Aukera.
Paul Bryson is co-founding a company with USC Professor Pin Wang, focusing on cancer treatment. Bryson holds an A.B. in biology from Princeton University, and a Ph.D. in microbiology and immunology from Stanford University.
Preet Chaudhary is co-founding a company focusing on cancer treatment. Chaudhary earned a MD from Delhi University and a Ph.D. from the University of Illinois, Chicago.
John Chi is the founder and CEO of Synova Life Sciences. Synova is commercializing a device to harvest stem cells from adipose tissue for use as a regenerative therapy for joints. Chi holds a B.S. in electrical engineering from Stanford University and a Master of Biotechnology from Cal State LA.
Steven Flanagan is developing improved Flavivirus vaccines. Flanagan holds a B.S. in biology from Caltech and a Ph.D. in biology from UC San Diego.
Robert Gellibolian is the founder of CellectGen, which is developing a saliva collection and processing device for point-of-care diagnoses and screenings for diseases. Gellibolian holds a B.S.in biochemistry from UCLA and a Ph.D. in biochemistry from Texas A&M University. He is joined by partner Adam Markaryan, co-founder and senior scientist at CellectGen.
Young-Kwon Hong is an associate professor of surgery at Keck School of Medicine of USC. He is developing improved methodology for endothelial cell culture and creating cell lines. Hong holds a B.S. in agricultural chemistry from Korea University and a Ph.D. in microbiology from UC Davis.
Arnold Suwarnasarn is an entrepreneur interested in 3D printing and connected preventative health through in-home sensor screening and neuroscience. Suwarnasarn holds a B.A. in biology from the University of Colorado, Boulder, a Ph.D. in bioengineering from UCLA, and a MBA from USC.
Xin Wen is developing antifreeze polypeptides as a preservative for temperature sensitive protein-based therapeutics or consumer products. Wen holds a B.S. in chemistry from Nanjing University and a M.S. and Ph.D. in biophysical chemistry from the University of Rochester. She is a Cal State LA professor and her team members, Rebecca Vargas and Tania Garcia, are Cal State LA students.
Qijin (Kevin) Xu
Qijin (Kevin) Xu is the founder and CEO of Xcell Unity Biotech Co., focusing on cancer detection, imaging and therapy, including immunotherapy. Xu holds a B.S. in geology and chemistry from Peking University, M.S. in protein chemistry from the Chinese Academy of Sciences, and a Ph.D. in molecular, cellular and developmental biology from the University of Michigan. He is joined by partners Yingduan Cheng, Zheng (Alex) Fu, Chunying Song, and Weidong Xiong.